Key Record Dates
ClinicalTrials.gov Identifier: | NCT03558503 |
---|---|
Brief Title: | A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer (OPTIMA II) |
First Submitted : | May 8, 2018 |
First Submitted that Met QC Criteria : | June 3, 2018 |
First Posted : | June 15, 2018 |
Certification/Extension First Submitted : | December 9, 2020 |
Certification/Extension First Submitted that Met QC Criteria : | December 9, 2020 |
Certification/Extension First Posted : | December 11, 2020 |
Last Update Submitted that Met QC Criteria : | December 9, 2020 |
Last Update Posted : | December 11, 2020 |